ImmunoVec

ImmunoVec is a biotechnology company focused on developing gene therapy treatments aimed at curing terminal genetic diseases of the immune system, specifically hematopoietic diseases. By utilizing innovative gene therapy techniques, the company seeks to provide effective solutions that enable patients to achieve healthier lifestyles. Through its research and development efforts, ImmunoVec aims to address significant unmet medical needs in the field of immunology.